NO172185C - Fremgangsmaate for fremstilling av glukagon - Google Patents

Fremgangsmaate for fremstilling av glukagon

Info

Publication number
NO172185C
NO172185C NO860178A NO860178A NO172185C NO 172185 C NO172185 C NO 172185C NO 860178 A NO860178 A NO 860178A NO 860178 A NO860178 A NO 860178A NO 172185 C NO172185 C NO 172185C
Authority
NO
Norway
Prior art keywords
glucagon
derivatives
expression
yeast
fragments
Prior art date
Application number
NO860178A
Other languages
English (en)
Norwegian (no)
Other versions
NO860178L (no
NO172185B (no
Inventor
Kjeld Norris
Lars Thim
Fanny Norris
Mogens Trier Hansen
Alister James Moody
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO860178L publication Critical patent/NO860178L/no
Publication of NO172185B publication Critical patent/NO172185B/no
Publication of NO172185C publication Critical patent/NO172185C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO860178A 1985-01-22 1986-01-20 Fremgangsmaate for fremstilling av glukagon NO172185C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK27885A DK27885A (da) 1985-01-22 1985-01-22 Fremstilling af peptider

Publications (3)

Publication Number Publication Date
NO860178L NO860178L (no) 1986-07-23
NO172185B NO172185B (no) 1993-03-08
NO172185C true NO172185C (no) 1993-06-16

Family

ID=8091749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860178A NO172185C (no) 1985-01-22 1986-01-20 Fremgangsmaate for fremstilling av glukagon

Country Status (17)

Country Link
US (1) US4826763A (fi)
EP (1) EP0189998B1 (fi)
JP (2) JPH0720435B2 (fi)
AT (1) ATE48643T1 (fi)
AU (1) AU587218B2 (fi)
CA (1) CA1294232C (fi)
DE (1) DE3667488D1 (fi)
DK (1) DK27885A (fi)
ES (1) ES8708250A1 (fi)
FI (1) FI87800C (fi)
GR (1) GR860149B (fi)
IE (1) IE58726B1 (fi)
MX (1) MX163776B (fi)
NO (1) NO172185C (fi)
NZ (1) NZ214883A (fi)
PT (1) PT81872B (fi)
ZA (1) ZA86393B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151354A (en) * 1986-08-21 1992-09-29 Cornelius Hollenberg Fermentation processes using amylolytic enzyme producing microorganisms
EP0268772B1 (en) * 1986-09-19 1995-04-26 ZymoGenetics, Inc. Expression of biologically active factor XIII
JPH01187499A (ja) * 1988-01-21 1989-07-26 Science & Tech Agency 原子炉解体用ロボット
ZA90533B (en) * 1989-02-01 1990-10-31 Shionogi & Co A method for the production of glucagon
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5510459A (en) * 1991-01-17 1996-04-23 Zymogenetics, Inc. Glucagon antagonists
US5408037A (en) * 1991-01-17 1995-04-18 Zymogenetics, Inc. Methods for detecting glucagon antagonists
WO1994001215A1 (en) * 1992-07-06 1994-01-20 Beckman Instruments, Inc. Fluid delivery system utilizing multiple port valve
DK144093D0 (fi) * 1993-12-23 1993-12-23 Novo Nordisk As
US5652216A (en) * 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
CA2289652C (en) * 1997-05-16 2012-02-28 1149336 Ontario Inc. Methods of enhancing functioning of the upper gastrointestinal tract
MXPA05006994A (es) * 2002-12-27 2005-10-18 Diobex Inc Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina.
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
DK3178835T3 (da) 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
PT2440228T (pt) 2009-06-08 2018-12-24 Amunix Operating Inc Polipéptidos de regulação da glicose e métodos de preparação e utilização dos mesmos
WO2013130683A2 (en) 2012-02-27 2013-09-06 Amunix Operating Inc. Xten conjugate compositions and methods of making same
ES2938734T3 (es) 2018-10-09 2023-04-14 Fresenius Kabi Ipsum S R L Procedimiento para la fabricación de análogos de GLP-1
US20220324936A1 (en) 2019-06-18 2022-10-13 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of glucagon
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
CN115175920A (zh) 2019-11-13 2022-10-11 阿穆尼克斯制药公司 加条形码的xten多肽及其组合物以及其制备和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401759A (en) * 1980-05-01 1983-08-30 Harvey Rubin Detection and isolation of glucagon mRNA using a synthetic oligodeoxynucleotide
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins

Also Published As

Publication number Publication date
NZ214883A (en) 1988-04-29
EP0189998A1 (en) 1986-08-06
ES551042A0 (es) 1987-10-01
ES8708250A1 (es) 1987-10-01
IE58726B1 (en) 1993-11-03
JPS61181398A (ja) 1986-08-14
CA1294232C (en) 1992-01-14
PT81872A (en) 1986-02-01
US4826763A (en) 1989-05-02
ZA86393B (en) 1987-03-25
NO860178L (no) 1986-07-23
DK27885A (da) 1986-07-23
NO172185B (no) 1993-03-08
FI860251A0 (fi) 1986-01-20
FI87800C (fi) 1993-02-25
ATE48643T1 (de) 1989-12-15
MX163776B (es) 1992-06-22
EP0189998B1 (en) 1989-12-13
AU587218B2 (en) 1989-08-10
GR860149B (en) 1986-05-21
DE3667488D1 (de) 1990-01-18
JPH0720435B2 (ja) 1995-03-08
PT81872B (pt) 1988-05-27
JPH06292594A (ja) 1994-10-21
JPH0746986B2 (ja) 1995-05-24
DK27885D0 (da) 1985-01-22
AU5247286A (en) 1986-07-31
FI87800B (fi) 1992-11-13
FI860251A (fi) 1986-07-23
IE860162L (en) 1986-07-22

Similar Documents

Publication Publication Date Title
NO172185C (no) Fremgangsmaate for fremstilling av glukagon
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
AU573768B2 (en) Hyaluronic acid from streptococci
HU9201712D0 (en) A mammalian cytokine, il-11
BG49717A3 (en) Method for preparing of chirudine
ES2169095T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen.
AU4833897A (en) Glial mitogenic factors, their preparation and use
EP0853121A3 (en) Human DNase
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
AU6733487A (en) Mammalian interleukin-4
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
AU682140B2 (en) Multidrug resistance gene
IE840258L (en) Expression of gene products.
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
DE3888459D1 (de) Zellzüchtung in kontinuierlicher Dispersionskultur mit einem System zur Gewinnung von Zellprodukten.
AU2179688A (en) Recombinant eukaryotic cells production interleukin-2, process and vectors for their preparation and process for the preparation of interleukin-2
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
ES2078243T3 (es) Mejoras en o relativas a la expresion eucariotica.
AU2430588A (en) Mutant acidic fibroblast growth factor
DE69130704D1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns-sequencen, und ihre herstellung und vewendung.
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
AU6286086A (en) An improved heat-shock control method and system for the production of competent eukaryotic gene products
DK28386A (da) Fremstilling af peptider
AU3434789A (en) The gene encoding phosphoribosylaminoimidazolecarboxylase of schwanniomyces occidentalis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees